MOGES
Morpho-functional
(D) Dilated
(H) Hypertrophic
(R) Restrictive
(A) ARVC
(NC) LVNC
(NS) Nonspecific phenotype
(NA) Information not available
(0) Unaffected
(E[D]) Early Diagnosis of Dilated
(E[H]) Early Diagnosis of Hypertrophic
(E[R]) Early Diagnosis of Restrictive
(E[A]) Early Diagnosis of ARCV
Clear
Add phenotype
Organ/system involvement
(H) Heart
(M) Muscle, Skeletal
(N) Nervous
(C) Cutaneous
(E) Eye
(A) Auditory
(K) Kidney
(G) Gastrointestinal
(S) Skeletal
(Lu) Lung
(Li) Liver
(0) Absence of organ/system involvment
Clear
Add organ info
Genetic
(N) Family History Negative
(U) Family History Unknown
(AD) Autosomal Dominant
(AR) Autosomal Recessive
(XLR) X-linked Recessive
(XLD) X-linked Dominant
(XL) X-linked
(M) Matrilineal
(DN) De novo
(0)
Etiological Annotation
(G) Genetic etiology
(G-OC) Obligate Carrier
(G-ONC) Obligate Non-Carrier
(G-DN) De novo
(G-C) Complex genetics (when > 1 mutation )
(G-Neg) Genetic test negative
(G-NA) Genetic test not yet available
(G-N) Genetic test not yet available
(G-A) Genetic Amiloydosis
(0) No genetic test
(M) Myocarditis
(V) Viral infection
(AI) Autoimmune/immune-mediate
(AI-S) Autoimmune/immune-mediate Suspected
(AI-P) Autoimmune/immune-mediate Proven
(A) Amyloidosis
(I) Infectious, non viral
(T) Toxicity
(Eo) Hypereosinophilic heart disease
(A-K) Amyloidosis type K
(A-L) Amyloidosis type L
(A-SSA) Amyloidosis type SSA
Description
Gene
Mutation
Clear
Add Gene
Stage
ACC-AHA stage
A
B
C
D
NYHA class
I
II
III
IV
M
0
O
0
G
0
E
0
S
Copyright © 2013
Biomeris Srl
,
info@biomeris.com
- All rights reserved